Skip to content
Menu

Ernexa Therapeutics Inc. ERNA

Full chart Compare
Set alert

Price alert · ERNA

All alert types
1.36 USD -0.27 (-16.56%)

Regular-session close

1.35 -0.01 -0.74%

After hours · Nov 20, 4:00 PM ET

1.35 Day range 1.60
1.36 52-week range 37.00
YTD
-95.47%
1 year
-95.75%

Revenue & Expenses

Revenue Profit Costs
Other Operating Income$1.58MGross Profit$486.00KNet Loss$44.54MCost of Revenue$96.00KExpenses$46.60MSelling, General & Admin$13.13MResearch & Development$4.60MInterest Expense$6.75MOther Expenses$22.08MIncome Tax$30.00KRevenue$582.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

ERNA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-9.10M-17.18M-21.14M-34.36M-113.73M
-14.08M-44.54M-21.67M-24.58M-122.55M
-56.00-1,224.00-1,531.00-3,022.00-21,229.00
ERNA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.88M1.73M11.67M15.54M16.98M
5.83M5.27M49.13M22.28M31.52M
3.43M3.57M46.90M10.17M6.02M
490.00K684.00K41.84M1.18M2.72M
2.40M1.70M2.23M12.11M25.50M
ERNA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-7.02M-15.84M-20.41M-20.98M-23.49M
-37.00K-365.00K-19.00K-47.00K-22.74M
7.21M6.26M16.56M19.58M61.59M
-37.00K-365.00K-19.00K-47.00K-154.00K
155.00K-9.94M-3.87M-1.44M15.36M